Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy

Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy

Recently, fibroblast activation protein (FAP), an overexpressed transmembrane protein of activated fibroblast in pulmonary fibrosis, has been considered as the new target for diagnosing and treating pulmonary fibrosis. In this work, mesoporous polydopamine (MPDA), which is facile prepared and easily...

Full description

Bibliographic Details
Main Authors:	Qi Fang, Shaoyu Liu, Jiangyu Cui, Ruiyue Zhao, Qian Han, Peng Hou, Youcai Li, Jie Lv, Xiaoyao Zhang, Qun Luo, Xinlu Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	mesoporous polydopamine fibroblast activation protein fibroblast activation protein inhibitor pulmonary fibrosis antifibrosis therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2022.920766/full

Similar Items

Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?
by: Nataliya Basalova, et al.
Published: (2023-11-01)

Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis
by: Sudan Wang, et al.
Published: (2022-03-01)

Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
by: Yan Cui, et al.
Published: (2023-09-01)

CARTing Away Cardiac Fibrosis∗
by: Jonathan A. Epstein, MD
Published: (2020-03-01)

Fibroblast Activation Protein Targeted Photodynamic Therapy Selectively Kills Activated Skin Fibroblasts from Systemic Sclerosis Patients and Prevents Tissue Contraction
by: Daphne N. Dorst, et al.
Published: (2021-11-01)

Role of Fibroblast Activation Protein Alpha in Fibroblast-like Synoviocytes of Rheumatoid Arthritis
by: Mohammad Javad Mousavi, et al.
Published: (2021-06-01)

Expression of fibroblast activating protein in eyelid basal cell carcinoma associated fibroblasts
by: Jin-Hui Zhou, et al.
Published: (2021-08-01)

Superhydrophilic Polyurethane/Polydopamine Nanofibrous Materials Enhancing Cell Adhesion for Application in Tissue Engineering
by: Kamil Kopeć, et al.
Published: (2020-09-01)

In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles
by: Hongping Xu, et al.
Published: (2022-12-01)

Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis
by: Ting Chen, et al.
Published: (2022-05-01)

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
by: Surachet Imlimthan, et al.
Published: (2021-10-01)

Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment
by: Yuhua Wang, et al.
Published: (2023-12-01)

[18 F] -FAPI-42 PET/CT assessment of Progressive right ventricle fibrosis under pressure overload
by: Xiaohui Zeng, et al.
Published: (2023-11-01)

Polydopamine Blending Increases Human Cell Proliferation in Gelatin–Xanthan Gum 3D-Printed Hydrogel
by: Preetham Yerra, et al.
Published: (2024-02-01)

Mesoporous polydopamine with built-in plasmonic core: Traceable and NIR triggered delivery of functional proteins
by: Wu, Di, et al.
Published: (2022)

Expression of fibroblast-activation protein in keloid tissue and its clinical significance
by: Yu-xiong ZOU, et al.
Published: (2020-10-01)

The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
by: Yuling Wang, et al.
Published: (2024-02-01)

Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis
by: Hong Peng, et al.
Published: (2024-04-01)

Highlights of Strategies Targeting Fibroblasts for Novel Therapies for Rheumatoid Arthritis
by: Cong-Qiu Chu
Published: (2022-02-01)

Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy
by: Zhang L, et al.
Published: (2019-11-01)

The subacute toxicity and underlying mechanisms of biomimetic mesoporous polydopamine nanoparticles
by: Bang-Yao Chen, et al.
Published: (2023-10-01)

Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and FibrosisSummary
by: Ai-Ting Yang, et al.
Published: (2023-01-01)

Targeting of activated fibroblasts for imaging and therapy
by: Thomas Lindner, et al.
Published: (2019-07-01)

Growth factors enhanced angiogenesis and osteogenesis on polydopamine coated titanium surface for bone regeneration
by: Jiuping Wu, et al.
Published: (2020-11-01)

Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
by: Jingrong Shao, et al.
Published: (2022-07-01)

Roles of Exosomes in Cardiac Fibroblast Activation and Fibrosis
by: Julia Hohn, et al.
Published: (2021-10-01)

Frontiers in Preparations and Promising Applications of Mesoporous Polydopamine for Cancer Diagnosis and Treatment
by: Hualin Ma, et al.
Published: (2022-12-01)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
by: Laura Gilardi, et al.
Published: (2022-02-01)

Toxicity Analysis of Mesoporous Polydopamine on Intestinal Tissue and Microflora
by: Luoyijun Xie, et al.
Published: (2022-09-01)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
by: Rita Saúde-Conde, et al.
Published: (2024-03-01)

2-Methoxyestradiol loaded mesoporous polydopamine nanoprobes for hypoxia alleviation and sorafenib synergistic treatment of hepatocellular carcinoma
by: Peifeng Wang, et al.
Published: (2023-08-01)

Mesoporous polydopamine nanoparticles carrying peptide RL-QN15 show potential for skin wound therapy
by: Pan Qin, et al.
Published: (2021-10-01)

Association between high expression of intratumoral fibroblast activation protein and survival in patients with intrahepatic cholangiocarcinoma
by: Yuhei Waki, et al.
Published: (2023-11-01)

Multifunctional mesoporous polydopamine near-infrared photothermal controlled release of kartogenin for cartilage repair
by: Zhen-Yu Luo, et al.
Published: (2023-07-01)

S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis
by: Wei Zhang, et al.
Published: (2018-06-01)

Polydopamine Nanomaterials: Recent Advances in Synthesis Methods and Applications
by: Vincent Ball, et al.
Published: (2018-08-01)

Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
by: Peng Liu, et al.
Published: (2023-01-01)

The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
by: Zahra Kalaei, et al.
Published: (2023-06-01)

Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
by: Leopoldo Sitia, et al.
Published: (2021-02-01)

Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target
by: K. Greimelmaier, et al.
Published: (2023-08-01)